Cargando…

Flexible modeling improves assessment of prognostic value of C-reactive protein in advanced non-small cell lung cancer

BACKGROUND: C-reactive protein (CRP) is gaining credibility as a prognostic factor in different cancers. Cox's proportional hazard (PH) model is usually used to assess prognostic factors. However, this model imposes a priori assumptions, which are rarely tested, that (1) the hazard ratio associ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gagnon, B, Abrahamowicz, M, Xiao, Y, Beauchamp, M-E, MacDonald, N, Kasymjanova, G, Kreisman, H, Small, D
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2010
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2853092/ https://www.ncbi.nlm.nih.gov/pubmed/20234363 http://dx.doi.org/10.1038/sj.bjc.6605603

Ejemplares similares

Montreal prognostic score: estimating survival of patients with non-small cell lung cancer using clinical biomarkers
por: Gagnon, B, et al.
Publicado: (2013)

VeriStrat(®) has prognostic value in advanced stage NSCLC patients treated with erlotinib and sorafenib
por: Kuiper, J L, et al.
Publicado: (2012)

Prognostic performance of inflammation-based prognostic indices in primary operable non-small cell lung cancer
por: Pinato, D J, et al.
Publicado: (2014)

Circadian function in patients with advanced non-small-cell lung cancer
por: Levin, R D, et al.
Publicado: (2005)

The prognostic impact of the neutrophil-to-lymphocyte ratio in patients with small-cell lung cancer
por: Kang, M H, et al.
Publicado: (2014)

HPV Prevalence and Prognostic Value in a Prospective Cohort of 255 Patients with Locally Advanced HNSCC: A Single-Centre Experience
por: Thibaudeau, E., et al.
Publicado: (2013)

Chemotherapy-induced neutropenia as a prognostic factor in advanced non-small-cell lung cancer: results from Japan Multinational Trial Organization LC00-03
por: Kishida, Y, et al.
Publicado: (2009)

Expression and prognostic value of JAM-A in gliomas
por: Rosager, Ann Mari, et al.
Publicado: (2017)

Flexibility of Older Adults Aged 55–86 Years and the Influence of Physical Activity
por: Stathokostas, Liza, et al.
Publicado: (2013)

Prognostic value of lymph node ratio and extramural vascular invasion on survival for patients undergoing curative colon cancer resection
por: Parnaby, C N, et al.
Publicado: (2015)

Validation of the prognostic relevance of plasma C-reactive protein levels in soft-tissue sarcoma patients
por: Szkandera, J, et al.
Publicado: (2013)

The Incidence and Prognostic Value of Hypochloremia in Critically Ill Patients
por: Tani, Makiko, et al.
Publicado: (2012)

Prognostic Value of Neutrophil-Related Factors in Locally Advanced Cervical Squamous Cell Carcinoma Patients Treated with Cisplatin-Based Concurrent Chemoradiotherapy
por: Wang, Yan-Yang, et al.
Publicado: (2016)

Prognostic value of histopathological regression in 850 neoadjuvantly treated oesophagogastric adenocarcinomas
por: Schmidt, T, et al.
Publicado: (2014)

Independent contributors to overall quality of life in people with advanced cancer
por: M Rodríguez, A, et al.
Publicado: (2013)

Prognostic/predictive value of 207 serum factors in colorectal cancer treated with cediranib and/or chemotherapy
por: Spencer, S K M, et al.
Publicado: (2013)

Modelling prognostic factors in advanced pancreatic cancer
por: Stocken, D D, et al.
Publicado: (2008)

Prognostic Value of VEGF in Patients Submitted to Percutaneous Coronary Intervention
por: Ramos, Catarina, et al.
Publicado: (2014)

The prognostic value of oxidative stress and inflammation in Chinese hemodialysis patients
por: Wang, Zhen, et al.
Publicado: (2016)

Prognostic role of topoisomerase-IIα in advanced ovarian cancer patients
por: Ferrandina, G, et al.
Publicado: (2008)

Prognostic value of Ki-67 for prostate cancer death in a conservatively managed cohort
por: Fisher, G, et al.
Publicado: (2013)

Pancreatic Resections for Advanced M1-Pancreatic Carcinoma: The Value of Synchronous Metastasectomy
por: Seelig, S. K., et al.
Publicado: (2010)

Phase II trial of S-1 and cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer
por: Ohyanagi, F, et al.
Publicado: (2009)

Surgical resection of brain metastases: the prognostic value of the graded prognostic assessment score
por: Jakola, A. S., et al.
Publicado: (2011)

Second primary cancer in survivors following concurrent chemoradiation for locally advanced non-small-cell lung cancer
por: Takigawa, N, et al.
Publicado: (2006)

Baseline tumour measurements predict survival in advanced non-small cell lung cancer
por: Gerber, D E, et al.
Publicado: (2013)

Prognostic value of the S100B protein in newly diagnosed and recurrent glioma patients: a serial analysis
por: Holla, F. K., et al.
Publicado: (2016)

Prognostic role of serum cytokeratin 19 fragments in advanced non-small-cell lung cancer: association of marker changes after two chemotherapy cycles with different measures of clinical response and survival
por: Nisman, B, et al.
Publicado: (2008)

HER3 genomic gain and sensitivity to gefitinib in advanced non-small-cell lung cancer patients
por: Cappuzzo, F, et al.
Publicado: (2005)

Endothelial Function Increases after a 16-Week Diet and Exercise Intervention in Overweight and Obese Young Women
por: Cotie, Lisa M., et al.
Publicado: (2014)

The prognostic value of pretreatment of systemic inflammatory responses in patients with urothelial carcinoma undergoing radical cystectomy
por: Ku, J H, et al.
Publicado: (2015)

Prognostic value of prostate circulating cells detection in prostate cancer patients: a prospective study
por: Eschwège, P, et al.
Publicado: (2009)

Phase II study of SPI-77 (sterically stabilised liposomal cisplatin) in advanced non-small-cell lung cancer
por: White, S C, et al.
Publicado: (2006)

Multivariate prognostic factors analysis for second-line chemotherapy in advanced biliary tract cancer
por: Fornaro, L, et al.
Publicado: (2014)

Predictive factors associated with prolonged survival in patients with advanced non-small-cell lung cancer (NSCLC) treated with gefitinib
por: Satouchi, M, et al.
Publicado: (2007)

Comparison of the prognostic value of longitudinal measurements of systemic inflammation in patients undergoing curative resection of colorectal cancer
por: Guthrie, G J K, et al.
Publicado: (2013)

Randomised phase II study of ASA404 combined with carboplatin and paclitaxel in previously untreated advanced non-small cell lung cancer
por: McKeage, M J, et al.
Publicado: (2008)

Brachial Artery Endothelial Responses during Early Recovery from an Exercise Bout in Patients with Coronary Artery Disease
por: Currie, Katharine D., et al.
Publicado: (2014)

Prognostic assessment in patients with newly diagnosed small cell lung cancer brain metastases: results from a real-life cohort
por: Steindl, Ariane, et al.
Publicado: (2019)

Phase II study of gemcitabine plus oxaliplatin as first-line chemotherapy for advanced non-small-cell lung cancer
por: Cappuzzo, F, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_60mr1985rm1iemlba8cbagb1k2